We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · November 19, 2018

Clinical Manifestations of Heterozygote Carrier With Rare VHL Gene Variant Responsible for Congenital Erythrocytosis

Written by
Xia Wang MD, PhD

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Ilene Sussman

    I recommend follow-up with the annual measurements of plasma free metanephrines. Best, Jacques Lenders


  • Xia  Wang

    Thank you, Dr. Lenders! Xia Wang, Moffitt Cancer Center


  • Oct 31, 2020

    Pending Moderator approval.
    Delete

Further Reading